RNA-labelled Ro and La ribonucleoprotein complexes reassembled in vitro; characterization by gel shift analysis

Clinical and Experimental Immunology

Volumn 106, Issue 3, 1996, Pages 498-503

  Granger, D ^a,b   Gendron, M ^a   Tremblay, A ^a,b   Chabot, B ^c   Menard H A ^a   Boire, G ^a,b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Autoantibody; Gel shift assay; La antigen; Ribonucleoproteins; Ro antigen

Indexed keywords

AUTOANTIBODY; LA ANTIGEN; RIBONUCLEOPROTEIN; RO ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; HELA CELL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029807089     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-861.x     Document Type: Article

References (16)

1. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93-151.
2. Wolin SL, Steitz JA. The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs. Proc Natl Acad Sci USA 1984; 84:1996-2000.
3. Gottlieb E, Steitz JA. Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III. EMBO J 1989; 8:851-61.
4. Mamula MJ, Silverman ED, Laxer RM et al. Human monoclonal anti-La antibodies. The La protein resides on a subset of Ro particles. J Immunol 1989; 143:2923-8.
5. Boire G, Craft J. Human Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide. J Clin Invest 1990; 85:1182-90.
6. Ben-Chetrit E, Chan EKL, Sullivan KF et al. A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med 1988; 167:1560-71.
7. Slobbe RL, Pluk W, van Venrooij WJ et al. Ro ribonucleoprotein assembly in vitro identification of RNA-protein and protein protein interactions. J Mol Biol 1992; 227:361 6.
8. Kelekar AA, Saitta MR, Keene JD. Molecular composition of Ro small ribonucleoprotein complexes in human cells. Intracellular localization of the 60- and 52-kD proteins. J Clin Invest 1994; 93: 1637-44.
9. Boire G, Gendron M, Monast N et al. Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol 1995; 100:489-98.
10. Boire G, Lopez-Longo FJ, Lapointe S et al. Sera from patients with autoimmune disease recognize conformational determinants on the 60-kD Ro/SS-A protein. Arthritis Rheum 1991; 34:722-30.
11. Boulanger C, Chabot B, Ménard HA et al. Autoantibodies in human anti-Ro sera specifically recognize deproteinized hY5 Ro RNA. Clin Exp Immunol 1995; 99:29-36.
12. Chabot B. Synthesis and purification of RNA substrates. RNA processing: a practical approach. In: Higgins SJ, Hames BD, eds. Oxford: IRL Press, 1994:1-29.
13. Dignam JD, Lebovitz RM, Roeder RC. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11:1475 89.
14. hY5 particle. J Clin Invest 1989; 84:270-9.
15. Meilof JF, Bantjes I, De Jong J et al. The detection of anti-Ro/SS-A and anti-La/SS-B antibodies. A comparison of counterimmuno-electrophoresis with immunoblot, ELISA, and RNA-precipitation assays. J Immunol Methods 1990; 133:215-26.
16. Tsuzaka K, Fujii T, Akizuki M et al. Clinical significance of antibodies to native or denatured 60-kD or 52-kD Ro/SS-A proteins in Sjögren's syndrome. Arthritis Rheum 1994; 37:88-92.